Clinical Trial Update: Calcium (ca),Phosphorus( P) and 25-hydroxyvitamin D(25OHD)] in Infants Born ≤ 32 PMA Gestational Weeks (GA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating calcium, phosphorus, and 25-hydroxyvitamin D in infants born at or before 32 weeks gestational age; status is currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Diseases
• Premature Infant Diseases

Drugs mentioned

• 25-Hydroxyvitamin D (25-hydroxyvitamin D)
• Calcium (Calcium)
• Phosphorus (phosphorus)

Snippet

Sponsor: Centre of Postgraduate Medical Education | Conditions: Infant, Premature, Diseases | Phase 3 | Status: UNKNOWN